| __timestamp | Ligand Pharmaceuticals Incorporated | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 152500000 |
| Thursday, January 1, 2015 | 13380000 | 187800000 |
| Friday, January 1, 2016 | 21221000 | 184000000 |
| Sunday, January 1, 2017 | 26887000 | 167700000 |
| Monday, January 1, 2018 | 27863000 | 218600000 |
| Tuesday, January 1, 2019 | 55908000 | 187400000 |
| Wednesday, January 1, 2020 | 59392000 | 177700000 |
| Friday, January 1, 2021 | 69012000 | 122000000 |
| Saturday, January 1, 2022 | 36082000 | 123100000 |
| Sunday, January 1, 2023 | 24537000 | 122500000 |
Cracking the code
In the ever-evolving pharmaceutical industry, innovation is the lifeblood of progress. Perrigo Company plc and Ligand Pharmaceuticals Incorporated, two prominent players, have shown contrasting approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Perrigo consistently invested significantly more in R&D, with expenditures peaking in 2018 at approximately 218 million dollars. In contrast, Ligand's R&D spending, while more modest, saw a remarkable surge in 2019, reaching nearly 69 million dollars, a 470% increase from 2014. This divergence highlights Perrigo's commitment to maintaining a robust pipeline, while Ligand's strategic spikes in investment suggest a focus on targeted innovation. As the pharmaceutical landscape continues to shift, these spending patterns offer valuable insights into each company's strategic priorities and potential future trajectories.
AbbVie Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Novartis AG vs Perrigo Company plc
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated